Management of related donor care: a European survey

S Clare1, A Mank, R Stone

  • 1Department of Clinical Haematology, Haematology Nursing Research and Practice Development, University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK. simon.clare@uclh.nhs.uk

Insights

Related donors face significant commitment. This study found a lack of standardized guidelines for managing related donors in European transplant centers, impacting patient autonomy and information access.

Area of Science:

  • Hematology
  • Transplantation Nursing
  • Medical Ethics

Background:

  • Donating bone marrow (BM) or peripheral stem cells is a demanding process for individuals.
  • Related donors require special consideration due to the personal relationship with the recipient.

Purpose of the Study:

  • To understand current practices in managing related donors across European transplant centers.
  • To identify gaps in guidelines, information provision, consent, and follow-up for related donors.

Main Methods:

  • A questionnaire was developed by the European Group for Blood and Marrow Transplantation-Nurses Group (EBMT-NG) research subcommittee.
  • The survey targeted delegates (N=150) at the 2005 EBMT-NG meeting, focusing on related donor management.
  • Key areas investigated included guidelines, patient information, donor consent, and follow-up services.

Main Results:

  • Information guidelines for patients primarily originated from local sources (52%).
  • Transplant information was mostly provided to related donors by the recipient's transplant team (57%).
  • Donor consent was obtained by transplant doctors in 52% of centers, while 25% used non-transplant doctors.

Conclusions:

  • There is a notable absence of recognized, standardized guidelines for the management of related stem cell donors.
  • Developing standardized guidelines is crucial for upholding donor autonomy, confidentiality, and access to objective information.
  • Standardization would enhance the overall care and ethical management of related stem cell donors.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...